1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Novo A Buys OrthoPediatrics Corp, Glaukos Corp, Sells AnaptysBio Inc, Flexion Therapeutics Inc, Reata Pharmaceuticals Inc

Investment company Novo A buys OrthoPediatrics Corp, Glaukos Corp, sells AnaptysBio Inc, Flexion Therapeutics Inc, Reata Pharmaceuticals Inc, KalVista Pharmaceuticals Inc, Apollo Endosurgery Inc during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Novo A. As of 2017-12-31, Novo A owns 13 stocks with a total value of $706 million. These are the details of the buys and sells.

For the details of Novo A's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Novo+A

These are the top 5 holdings of Novo A
  1. Inogen Inc (INGN) - 3,549,320 shares, 59.83% of the total portfolio.
  2. Acceleron Pharma Inc (XLRN) - 1,553,937 shares, 9.34% of the total portfolio.
  3. Dermira Inc (DERM) - 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%
  4. Corvus Pharmaceuticals Inc (CRVS) - 3,244,046 shares, 4.76% of the total portfolio.
  5. Akebia Therapeutics Inc (AKBA) - 2,225,000 shares, 4.68% of the total portfolio. Shares added by 17.88%
New Purchase: OrthoPediatrics Corp (KIDS)

Novo A initiated holding in OrthoPediatrics Corp. The purchase prices were between $17.5 and $21.82, with an estimated average price of $19.11. The stock is now traded at around $17.26. The impact to a portfolio due to this purchase was 1.03%. The holding were 379,014 shares as of 2017-12-31.

New Purchase: Glaukos Corp (GKOS)

Novo A initiated holding in Glaukos Corp. The purchase prices were between $24.5 and $36.01, with an estimated average price of $29.8. The stock is now traded at around $31.75. The impact to a portfolio due to this purchase was 0.57%. The holding were 156,429 shares as of 2017-12-31.

Sold Out: AnaptysBio Inc (ANAB)

Novo A sold out a holding in AnaptysBio Inc. The sale prices were between $35 and $100.8, with an estimated average price of $73.45.

Sold Out: Flexion Therapeutics Inc (FLXN)

Novo A sold out a holding in Flexion Therapeutics Inc. The sale prices were between $19.62 and $29.93, with an estimated average price of $24.46.

Sold Out: Reata Pharmaceuticals Inc (RETA)

Novo A sold out a holding in Reata Pharmaceuticals Inc. The sale prices were between $22.39 and $33.27, with an estimated average price of $27.94.

Sold Out: KalVista Pharmaceuticals Inc (KALV)

Novo A sold out a holding in KalVista Pharmaceuticals Inc. The sale prices were between $6.8 and $13.54, with an estimated average price of $10.41.

Sold Out: Apollo Endosurgery Inc (APEN)

Novo A sold out a holding in Apollo Endosurgery Inc. The sale prices were between $3.97 and $5.69, with an estimated average price of $4.55.



Here is the complete portfolio of Novo A. Also check out:

1. Novo A's Undervalued Stocks
2. Novo A's Top Growth Companies, and
3. Novo A's High Yield stocks
4. Stocks that Novo A keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


gluon71gm-buylist-2
gluon71gm-buylist-1
draperb9Mid Cap low PEG
jdvoytekValue
Stephen Neumeier30% plus loss 1 Year 500 Milli
vikas_salgiaPREDICTABLE BIZ
MRMARKETZ54Value,Dividends,Small co.
John DorfmanPrice to Revenue
John DorfmanPrice to Sales
PUEBLOCUSTOMIZED
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK